Core Viewpoint - NeuroOne Medical Technologies Corporation is set to release its financial results for the fiscal third quarter ending June 30, 2025, on August 14, 2025, before market open [1] Group 1: Financial Results Announcement - The financial results will be discussed in an investor conference call and webcast scheduled for August 14, 2025, at 8:30 a.m. Eastern time [2] - Participants can join the call using specific dial-in numbers and access codes provided [2] Group 2: Company Overview - NeuroOne focuses on developing minimally invasive and high-definition solutions for EEG recording, brain stimulation, and ablation for various neurological disorders [4] - The company aims to improve patient outcomes and reduce procedural costs, with potential applications in areas such as depression, mood disorders, and high blood pressure [4]

Core Insights - NeuroOne Medical Technologies Corporation announced that Clara, an early patient treated with the OneRF Ablation System, has surpassed one year seizure-free, significantly improving her quality of life [1][2] - The OneRF Ablation System is the first FDA 510(k)-cleared device that utilizes the same sEEG electrode for both diagnostic and therapeutic applications, demonstrating seizure reduction or freedom for most patients treated [3] - The company plans to leverage the OneRF technology for additional applications, including the OneRF Trigeminal Nerve Ablation System for facial pain, with a 510(k) submission filed in April 2025 [4] Company Overview - NeuroOne Medical Technologies Corporation focuses on developing minimally invasive and high-definition solutions for various neurological disorders, including epilepsy, Parkinson's disease, and chronic pain, aiming to improve patient outcomes and reduce procedural costs [5] - The company is exploring potential applications in other areas such as depression, mood disorders, and artificial intelligence [5]